Information on absorption and metabolism of strawberry polyphenols is limited. OBJECTIVE: The aim of this study was to characterize and quantify plasma polyphenols/anthocyanins across 4 doses of strawberry using Q-TOF LC/MS and LC-MS/MS analysis. METHOD: Plasma was collected from 5 subjects (n = 5) every 30-60 min for 6 h after consuming beverages containing 0, 10, 20 or 40 g freeze-dried strawberry powder with a meal. RESULTS: Q-TOF LC/MS and LC-MS/MS analysis of plasma revealed 33 compounds; 7 not reported previously. Pelargonidin-O-glucuronide (PG) was the most abundant metabolite. Maximum concentrations (C max ) of PG were achieved at 148 ± 31 min and were significantly different among beverages containing 0, 10, 20, 40 g strawberry powder: 0, 93.4 ± 21.9, 166.5 ± 16.2 and 226.7 ± 36.7 nmol/L, respectively (P < 0.05). Area under the concentration curve (AUC) also increased with dose (P < 0.05); however, C max and AUC of PG was reduced as a percent of pelargonidin-3-O-glucoside (P3G) delivered in the strawberry beverages (P < 0.05). CONCLUSION: Use of both Q-TOF LC/MS and LC-MS/MS allowed for detection of compounds in plasma not previously reported, which may be a useful approach for characterizing postprandial plasma metabolites of lesser known plant foods. Additionally, higher concentrations of key strawberry compounds/metabolites are achieved with eating more strawberry; however, saturation of absorptive capacity of pelargonidin-based anthocyanins was suggested.
Introduction
Interest in berry fruits for their beneficial health effects has increased dramatically in recent years. Strawberries, blueberries, blackberries and raspberries have received the most attention due to their content and composition of bioactive compounds such as anthocyanins, catechins and flavanols [1] [2] [3] . Studies conducted both in vitro and in vivo using berries (as whole fruit) or their phytochemical constituents suggest an important role in reducing the risk of cancer [4, 5] , atherosclerosis [6] diabetes [7] [8] [9] , age-related memory decline [10] and more [11] .
Specifically, consumption of strawberries by humans in doses ranging from ∼100 g to 500 g fresh weight have been shown to decrease fasting lipid concentrations and attenuate postprandial oxidative-and inflammatory-stress concurrent with improved postprandial insulin action [12] [13] [14] [15] [16] . Presumably, much of the documented effects of strawberries are owed to the antioxidant and cell signaling properties of the polyphenolic, particularly anthocyanin, compounds they provide when consumed. Strawberries are unique in that ∼98 percent of their total anthocyanin content is derived from pelargonidin-based anthocyanins with pelargonidin-3-O-glucoside providing the greatest contribution; ∼84 percent [15] , which is among other things, cultivar-dependent. Pelargonidin-3-O-glucoside is considered one of the most bioavailable anthocyanins and can be found in plasma and urine in its native form or as methylated, glucuronidated or sulfated conjugates [16] [17] [18] . Pelargonidin-O-glucuronide is the predominant plasma metabolite associated with strawberry consumption with measurable amounts of pelargonidin-sulfate [16] [17] [18] . However, in general, studies examining bioavailability of anthocyanins indicate that they are poorly absorbed and, in the case of some anthocyanins, thresholds for maximum absorption may be apparent [17, 19, 20] . Since it is generally assumed that to impart benefit, nutrients/bioactive components must be absorbed, factors that influence their bioavailability and the metabolites they bestow are of interest. Recent studies examining the bioavailability of pelargonidin and other anthocyanins of strawberry suggest that storage, dose and dietary fat can impact absorption kinetics and metabolite concentrations [18, [21] [22] [23] . However, no studies that we are aware of have examined strawberry consumed over multiple doses in a typical meal setting, in a beverage with a complete meal. Because meals, and particularly western style meals, are pro-oxidative and pro-inflammatory, it is of interest to determine the relative bioavailability and absorption kinetics of strawberry bioactives in a situation where the availability of the fruit components will be important for attenuating unfavorable meal-induced responses. Therefore, the primary focus of the present study was to characterize the plasma profile of strawberry anthocyanins, particularly the pelargonidin-based anthocyanins across 4 doses during the postprandial phase of metabolism; and secondly, to investigate the utility of employing targeted and non-targeted analysis approaches to advance our understanding of secondary-plant metabolite handling in vivo.
Methods

Subjects
The investigation involved human subjects and was conducted according to the guidelines laid down in the Declaration of Helsinki. All procedures involving human subjects were approved by the local Institutional Review Board, which protects the rights and welfare of human subjects in research studies conducted under the auspices of the Illinois Institute of Technology, IL, USA. All subjects provided written informed consent prior to any study related procedures.
Five subjects participated in this pilot study. Subjects were recruited from the Chicago, IL, USA community and met basic inclusion/exclusion exclusion criteria including: 18 years or older, non-smokers, and have no allergies or intolerances to strawberries or other study foods. Individuals with diabetes mellitus or other metabolic/systemic diseases/disorders or used medications or dietary supplements that would interfere with study endpoints were not eligible to participate. Participants were obese [body mass index (BMI) of 42.1 ± 9.7] men (n = 1) and women (n = 4).
Study design, treatments and procedures
This was a single-center, randomized, single-blind, four-arm, cross-over trial conducted at the Clinical Nutrition Research Center (CNRC) at the Institute of Food Safety and Health, Illinois Institute of Technology in Chicago, Illinois. The basic design involved the administration of a test meal with treatment beverages followed by periodic blood sampling. Eligible subjects were required to avoid consuming berries, including strawberries, while maintaining all other aspects of their diet and physical activity for the duration of the experiment, starting 7 days before the first study day session. During the experimental period, subjects consumed four test meals in random order on four different Table 1 Test meal for postprandial study days occasions so that each subject served as his/her own control. Test meals consisted of breakfast food items (Table 1) , which were accompanied by 1 of 4 beverages (Table 2) containing 0, 10, 20 or 40 g freeze-dried strawberry powder (California Strawberry Commission, Watsonville, CA, USA-The detail polyphenolic composition of California strawberry powder is given in Table 5-ref 15 ). The composition of beverages was closely matched in terms of total energy, macronutrients, vitamin C and fiber content (Table 3 ). All beverages were prepared fresh in the metabolic kitchen at the CNRC. Beverage ingredients were weighed on a scale to 0.1 g. All ingredients except for the freeze-dried strawberry powder were mixed in a blender until smooth. The freeze-dried strawberry powder was sprinkled into the smooth mixture while continuing to blend. After transferring the beverage to a cup, the blender was rinsed and the rinse water was added to the smoothie beverage. Following consumption of the beverage, the cup was also rinsed with water, which was then consumed by the subject to maximize the accuracy of anthocyanin intake. Beverages were served with meals in non-transparent cups with opaque lids and straws.
The postprandial test was conducted according to a standardized protocol [15] . Briefly, the subjects reported to the laboratory in the morning in a fasting state on four occasions 3-5 d apart. Indwelling catheters were placed in the antecubital vein of the non-dominant arm of the subjects, and blood samples were collected to EDTA tubes before (time 0 min) and at multiple time points after the meal, 30, 60, 90, 120 min, and then hourly, thereafter, to 6 h. EDTA plasma was stored at −80 • C until used for analysis. The meal and the beverages were consumed entirely under supervision in 20 min.
Chemicals
Pelargonidin-3-O-glucoside, pelargonidin-chloride, cyanidin-3-O-glucoside, (+)-catechin, ellagic acid, isoquercetin, kaempferol, quercetin-3-O-glucoside and kaempferol-3-O-rutinoside were purchased from Chromadex Inc. (Santa Ana, CA). All solvents were HPLC-MS grade and were purchased from Fisher Scientific (Pittsburg, PA).
Plasma and beverage sample preparation
Prior to extraction, 50 L of delphinidin-3-O-glucoside (1 g/mL) was added to 500 L of plasma samples as an internal standard. Samples were acidified to pH 2 with formic acid (FA) and extracted with 1.5 mL of acetonitrile (ACN), centrifuged at 10,000 rpm for 15 min at 4 • C then re-extracted with 1.5 mL methanol. Extracts were pooled, evaporated under nitrogen at 35 • C, reconstituted in 250 L of mobile phase and centrifuged at 10,000 rpm for 30 min at 4 • C. Samples were transferred to amber HPLC vials and immediately analyzed by Q-TOF LC/MS and by LC-MS/MS.
Beverages containing 0, 10, 20, or 40 g freeze dried strawberry powder were also prepared for analysis. In brief, a triplicate of each 1 mL sample was extracted with 15 mL of acetone:water (70:30, v/v) by shaking for 20 min. Samples were then centrifuged at 10,000 rpm and the clear extract was dried under nitrogen at 35 • C. Dried pellets were then dissolved in 2 mL of mobile phase filtered through a 0.2 m PTFE syringe filter (Phenomenex, Torrance, CA) and submitted for LC-MS/MS analysis. Table 4 shows a list of polyphenolic compounds detected in the strawberry-based beverages by LC-MS/MS.
LC-MS/MS and Q-TOF LC/MS analysis
Sample analysis was performed on an Agilent Technologies 1260 Infinity HPLC system with a 6460 Triple Quadruple Mass Spectrometer (Agilent Technologies, Santa Clara, CA) and a 1290 Infinity HPLC system (Agilent Technologies) coupled with an Agilent 6530 Accurate-Mass Q-TOF LC/MS system. Samples were placed in cooled autosamplers (4 • C) to maintain sample stability throughout the analysis.
Chromatographic separation on both systems was achieved on Agilent Poroshell 120 SB-C18 3.0 × 150 mm, 2.7 m columns (Agilent Technologies). The mobile phase was a gradient of 0.2% FA in water (A) and ACN (B) at a flow rate of 0.3 ml/min. The gradient starting composition was 2% B increasing to 100% B over 15 min followed by a 4 min post-run. For both instruments detection was carried out by using electrospray ionization (ESI) with nebulizer Table 4 Qualitative analysis of polyphenolic compounds in strawberry-based beverage Pelargonidin-3-malonyl-rhamnoside + 10. Since there is a resistance towards using fast polarity switching within one run due to a potential sensitivity loss, an analysis was performed to validate the fast polarity switching against standard methods utilizing either positive or negative ion mode (data not shown). No significant reduction of sensitivity was observed; therefore the positive and negative ion mode methods were combined. The LC-MS/MS analysis was carried out using Multiple Reaction Monitoring (MRM) by monitoring specific transitions of parent and product ions. Compounds were quantified using reference standards where available. Otherwise, relative quantitation was applied. Matrix-matched pelargonidin-3-O-glucoside standard curve (range 0.1-1000 ng/mL) was used to relatively quantify all pelargonidin-based compounds.
Calculations and statistical analysis
Maximum plasma concentrations (C max, nmol/L) were determined based on the highest concentration of metabolites measured from 0 to 6 h post dose. The time to maximum plasma concentrations (T max ) was defined as the time in minutes (min) at which C max was achieved. Incremental area under the 6 h concentration curves (AUC, nmol/L*h) was calculated using the linear Trapezoidal Method. Elimination rate constant (k e, h−1 ) was calculated from the following equation based on data collected during the elimination phase of the time-concentration curves: k e = −[ln(C 1 )-ln(C 2 )]/t 1 -t 2 , where C = concentration and t is time. Relative bioavailability was calculated based on pelargonidin-O-glucuronide AUC 0-6 h corrected for individual plasma volume based on sex and body weight (kg) according to the methods described in the technical manual of American Association of Blood Banks (AABB) [24] , where plasma volume is estimated to be 36 mL/kg for women and 40 mL/kg for men. Percent recovery/bioavailability was calculated by dividing the plasma mass (nmol) by the mass of pelargonidin-3-O-glucoside per dose (mol) and multiplying by 100.
Statistical analysis was performed using Sigma Plot statistical program version 11.2 (Systat Software Inc. San Jose, CA) and SAS (version 9.1.3; SAS Institute Inc, Cary, NC). All data were tested for normality and equal variance prior to analysis by one way analysis of variance (ANOVA) using Sigma Plot and repeated measures (RM-ANOVA) using MIXED procedure of SAS. Statistical significance was considered with P values <0.05. Results are given as the mean ± SEM or mean ± SD as indicated, n = 5. Post hoc power analysis indicated that sufficient power (>80%) was provided with the sample size (n = 5) on plasma outcome variables reported. Table 4 shows the qualitative analysis of strawberry polyphenols in strawberry beverages by LC-MS/MS. Quantitative analysis of anthocyanins indicated that the four doses of strawberry powder (0, 10, 20, 40 g) in beverages delivered 0.1 ± 0.0, 100.9 ± 2.7, 210.3 ± 5.7 and 368.8 ± 12.1 mol of anthocyanins of which pelargonidin-3-O-glucoside was 0, 81.3 ± 1.8, 166.8 ± 4.5 and 285.8 ± 8.9 mol, respectively. The total pelargonidin-based anthocyanin content per dose was 0, 97.1 ± 1.9, 200.4 ± 6.2 and 346.6 ± 10.1 mol, respectively.
Results
Treatment beverages
Q-TOF LC/MS analysis of polyphenols in plasma
The analysis of polyphenolic compounds in plasma using Q-TOF LC/MS consisted of three key steps. First, the acquired data were subjected to an algorithm called Molecular Feature Extractor (MFE) which resulted in determination of over 600 compounds present in human plasma. The second step was importing the initially processed data into Mass Profiler (MP) program to perform differential analysis of plasma samples with regard to treatment, time, and subjects. Once the analysis was completed, a database search was performed to identify specified compounds.
Qualitative Q-TOF LC/MS analysis of human plasma after strawberry consumption revealed 33 phenolic compounds and their metabolites (Table 5) . Of these compounds, 26 have been reported previously in studies on strawberry polyphenols [1-3, 18, 25, 26 ] and 7 have not been mentioned before as metabolites recovered in human plasma. Fisetin aglycone (mass 286.0469 Da) and its glycosylated form -fisetin-3-rutinoside (mass 594.1583 Da), have not been reported in any of the human studies on strawberry polyphenols, although fisetin is known to be a flavonoid naturally occurring in strawberry fruit [9, 27] . Similarly three additional pelargonidin metabolites were identified in plasma: pelargonidin-3-O-6 -rhamnosylglucoside (mass 579.1503 Da), 5-carboxypyranopelargonidin-3-O-glucopyranoside (mass 501.1034 Da) and pelargonidin-3-(6 -caffeoylglucoside) (mass 595.1461 Da). Quercetin-3-(6 -caffeoylgalactoside) at mass 626.1213 Da, quercetin-3-(2 , 6 -digalloylgalactoside) at mass 768.1174 Da and kaempferol-3-(6 -caffeoylglucosyl)-(1->2)-galactoside (mass 772.1850 Da) were also detected in post prandial plasma. The selectivity offered by accurate mass Q-TOF analysis with MS fragmentation allowed detection of trace metabolites, which permitted their identification and assessment of their relative appearance in plasma based on the sampling procedure. Time of appearance based on the sampling protocol of identified compounds/metabolites is shown in Table 6 . After consumption of the placebo beverage, only 4-hydroxybenzoic acid (reported also by Azzini et al. [18] in the baseline and strawberry postprandial plasma) and quercetin-3-glucoside were detectable in all 5 subjects 30 min post prandial. However, p-coumaric acid and quercetin were also detected at 30 min postprandial in two subjects. Consumption of the test beverages containing 10, 20 and 40 g of strawberry powder resulted in the appearance of 8, 10 and 13 compounds, respectively at 30 min. Between 60 and 180 min, ∼22 out of 33 compounds were detectable. Some compounds were detected late in the postprandial period, for instance quercetin-3-(6 -caffeylgalactoside), quercetin-rutinoside, 5-carboxypyranopelargonidin-3-O-beta-glucopyranoside, kaempferol 3-(6 -caffeylglucosyl)-(1->2)-galactoside were first detectable at approximately 180 minutes; however, for the latter 3 compounds, as dose increased appearance tended to be earlier in most subjects. Table 6 Phenolic compounds in plasma based on time (min) of first appearance determined by Q-TOF MS 1 
Compound
Time 1 Values represent Mean time ± SD based on sampling protocol, n = 5 subjects, 9 time points per subject. 2 Detected in two out of five subjects. 3 Detected in four out of five subjects. Table 7 shows the maximum concentrations achieved for the most abundant anthocyanins detected in plasma after consuming the four experimental beverages. Maximum concentrations did not significantly differ by dose for pelargonidin-3-O-glucoside; however, concentrations achieved after consumption of the highest dose (40 g strawberry powder-containing beverage) tended to be higher compared to the lowest dose (10 g strawberry powder beverage), p = 0.06. Significant increases were observed across the four doses for the major pelargonidin metabolite, pelargonidin-O-glucuronide (P < 0.01). Doubling the dose of strawberry powder from 10 g to 20 g in the strawberry beverage resulted in ∼40% higher pelargonidin-O-glucuronide C max and doubling the dose from (2), two major anthocyanins present in strawberries. Table 7 Peak anthocyanin concentrations in plasma 1 
LC-MS/MS analysis of pelargonidin glycosides in plasma
Compound
Treatment (Table 2) containing 0, 10, 20, 40 g freeze-dried strawberry powder. Treatment beverages were consumed with a meal (composition shown in Table 4 ). * Indicates P = 0.06 vs 0 g strawberry powder beverage (placebo).
20 g to 40 g strawberry powder resulted in ∼25% higher pelargonidin-O-glucuronide C max . Peak concentrations were achieved at 148 ± 31 min. Maximum concentrations achieved after controlling for dose of pelargonidin-3-Oglucoside (Table 8) indicated that pelargonidin-O-glucuronide decreased significantly (on a percent dose basis). Pelargonidin-O-glucuronide (m/z 447) was the most abundant anthocyanin present in plasma after ingestion of strawberry beverages (Fig. 2) . Three additional peaks with m/z 447 and a loss of 176 amu were also detected and corresponded to other isomeric forms of pelargonidin-O-glucuronide. Quantitation of pelargonidin-O-glucuronide was based only on the most abundant isomer (the additional peaks were under the limit of quantitation (LOQ) level for pelargonidin-O-glucuronide). Figure 3 illustrates the dose-response plasma profile of total pelargonidin-O-glucuronide concentrations over 6 h. Consistent with the C max data; AUC analysis indicated a significant dose-related increase in pelargonidin-Oglucuronide over the 6 h period (Table 8) . However, expressed according to the dose of pelargonidin-3-O-glucoside consumed, AUC of plasma pelargonidin-O-glucuronide decreased at the highest dose level (40 g strawberry-powder containing beverage) compared to the 10 g and 20 g strawberry powder-containing beverages. The relative percent bioavailability of the parent pelargonidin-3-O-glucoside compound (determined from 6 h plasma pelargonidin-3-Oglucoside) was 0.26% ± 0.07, 0.14% ± 0.05 and 0.10% ± 0.05 for 10, 20 and 40 g strawberry powder-containing beverages, respectively. Relative bioavailability of pelargonidin-3-O-glucoside based on its major metabolite pelargonidin-O-glucuronide, was 1.7% ± 0.3, 1.6% ± 0.3, 1.2% ± 0.2 for 10, 20, 40 g strawberry powder-containing beverages, respectively, p < 0.0001), consistent with the work of others [18, 12, 23] .
Cyanidin-3-O-glucoside is the next most abundant anthocyanin in strawberry (4.1 mg/100 g FW), which is approximately 6.5% of total strawberry anthocyanins. The dose of cyanindin-3-O-glucoside consumed in the 4 beverages was 0, 3.8 ± 0.1, 9.8 ± 1.3 and 22.1 ± 1.2 mol for 0, 10, 20, 40 mg strawberry powder-containing beverages, respec- Table 8 Extent and rate of absorption of pelargonidin-3-O-glucoside based on Pelargonidin-O-glucuronide in plasma after consumption of placebo and strawberry containing beverages 1 Treatment Dose (P3G) 3 AUC PG 4 AUC PG/Dose Cmax PG Cmax PG/Dose Table 2) . Treatment beverages were consumed with a meal (Table 4) tively. Maximum concentrations of cyanidin-3-O-glucoside increased ∼20% after doubling the dose from 10 to 20 mg and ∼30% after doubling the dose from 20 to 40 g. Internal standard (delphinidin-3-O-glucoside) recoveries were in a range of 88-115% for all analyzed samples.
Discussion
The purpose of the present study was to contribute to the growing body of knowledge of anthocyanin metabolism focusing on pelargonidin-based anthocyanins and their metabolites in plasma after consuming multiple doses of strawberry in a beverage with a complete meal using targeted and non-targeted analysis approaches enabled by advances in mass spectrometry. The findings of this study confirm previous work that pelargonidin-O-glucuronide is the primary pelargonidin metabolite found in plasma after strawberry consumption [11, 15, 18, 21, 25, 26] . However, while the maximum concentration in plasma and area under the concentration-time curve increased with dose; concentrations of pelargonidin-O-glucuronide decreased as a percent of dose, suggesting possible saturation of absorptive mechanisms or increased efficiency in elimination. The non-targeted Q-TOF LC/MS analysis was consistent with the requisite for identification of new and confirmation of previously reported metabolites in postprandial plasma after strawberry consumption. Furthermore, the analysis presented novel insights into the timeframe of metabolic changes that occur after consumption of pelargonidin-rich strawberry containing beverages.
The emerging health benefits of anthocyanins and strawberries as a favorite fruit to deliver anthocyanins warrants investigation of the absorption and metabolism of strawberry anthocyanins. To our knowledge, only 2 other investigations have examined bioavailability of strawberry anthocyanins over multiple doses [22, 23] and both utilized urinary excretion as a means for estimating bioavailability. Carkeet et al. [23] reported that strawberry anthocyanin (from puree) excretion increases linearly with doses from 15-60 mol anthocyanins and recovery as a percent of dose was ∼2%. Hollands et al. [22] reported that doses of fresh strawberries (100-400 g) delivering approximately 57-228 mol anthocyanins per dose also resulted in linear urinary anthocyanin excretion. In the present study, a dose range of 101-368 mol strawberry anthocyanins (∼81-286 mol pelargonidin-3-O-glucoside) was ingested and plasma concentrations of major anthocyanins and their metabolites were quantified. Direct measurement of the maximum concentrations achieved (C max ) and calculations of extent of exposure (AUC 0-6h ) indicated dose-related increases in both kinetic parameters during the 6 h experimental period. However, after controlling for dose, AUC 0-6h decreased ∼28% at the highest strawberry dose compared to the 10 g dose. Decreases of ∼17 and 20% were also apparent relative to dose based on C max comparing differences from 10 to 20 g strawberry powder in the beverages and 20 to 40 g strawberry powder in the beverages, respectively. These decreases suggest saturation of absorptive mechanisms or increased rates of elimination. We found no significant differences in elimination rate constants (k e ) among doses: 10, 20, 40 g strawberry powder containing beverages, k e = 0.09 ± 0.02 h −1 , 0.10 ± 0.02 h −1 , 0.12 ± 0.04 h −1 , respectively, suggesting but not confirming changes in efficiency at the level of absorption. Kurilich et al., reported maximal absorption at 350 mol (or less) of cyanidin-based anthocyanins, and saturation mechanisms for tea catechins and carotenoids has also been reported [19, 28, 29] . The apparent saturation supports absorptive transporter involvement, which has been described and reviewed previously [30] . It is noteworthy that our experimental design like others is based on single doses of strawberry. Ferruzzi and colleagues (2009) reported increased bioavailability of gallic acid and catechins from higher doses of grape seed polyphenol extract with repeated dosing in rats compared to a single dose protocol [31] . Whether regular consumption of higher doses of strawberries (anthocyanins) would increase efficiency of absorption of these compounds requires further investigation.
Previously published human studies investigating strawberry anthocyanins kinetic parameters have tested anthocyanin absorption and excretion after ingestion of a single dose in various forms (fresh or frozen strawberries) with little or no accompanying food [18, [21] [22] [23] 32] . Administering anthocyanin-rich fruit with or without food/meal, as well as composition of the food/meal would be expected to affect absorption and or the kinetics of valuable bioactives, as suggested by Mullen et al. [21] . In this study, subjects consumed four different doses of strawberry in a beverage with a meal representing modern day western eating patterns. Modern day meals induce oxidative stress and inflammation due to their relatively high and readily available carbohydrate and fat content. One of the beneficial effects anthocyanin-rich fruits may have on health is to relieve meal-induced oxidative and metabolic imbalances. Therefore, strawberry anthocyanin/pelargonidin bioavailability was assessed and polyphenols and metabolites were profiled during a typical post meal period. Estimates of bioavailability from other studies ranged from 0.75% to 2.4% [18, [21] [22] [23] and in the present study we estimated bioavailability to range from 1.2-1.7%, decreasing at the highest dose of strawberry consumed (40 g strawberry powder, ∼286 mol pelargonidin-3-O-glucoside). Our estimates of bioavailability in general (∼1.5%) are consistent with previous reports. This is the first time that we are aware strawberry anthocyanin bioavailability has been examined in a large meal setting, which could have played a role in anthocyanin bioavailability. One limitation of the study was that we only had plasma collections to 6 h postprandial. Because of the large meal, absorption would be expectedly slowed (compared to drinking the beverages alone) resulting in prolonged absorption time and potentially increased absorption at lower segments of the small intestine. Likewise, metabolite contribution from large bowel microbial metabolism may be altered depending on remaining substrate to pass from the small to large bowel. Whether the metabolite profile would change under these conditions is speculative and would not be reflected in the glucuronide metabolites we focused on in this study for assessing bioavailability. Assessing time of appearance of various plasma compounds provided insight into the profile of metabolites within different time frames postprandially according to dose; however, a second limitation of the study was that we did not have a second control arm whereby beverages were consumed without a meal. Nonetheless, the time of appearance analysis provided another example of how chemical structure of polyphenols modulates their intestinal absorption. The rate and extent of metabolite appearance in plasma varies from one phenolic compound to the next and can also be affected by the foods it is consumed with [21] . Chemical structures of dietary polyphenols also influence their conjugation with glucuronide, sulfate or methyl groups and the amounts of formed metabolites [33] . The conjugates can be also hydrolyzed by the colonic microbiota and the resulting aglycone reabsorbed or further metabolized to low molecular weight aromatic acids such as, observed in current study, 4-hydroxybenzoic acid. Thus, understanding the structural features affecting absorption of polyphenolic compounds is a key in determining their metabolic path. Future studies will need to be longer in time and have a control condition without a meal to discern the contribution of alimentary handling on anthocyanins/pelargondinin absorption and metabolism.
Anthocyanins and their metabolites were identified in plasma using LC-MS/MS and Q-TOF LC/MS as described in the methods. Numerous compounds were identified, of which pelargonidin-O-glucuronide, pelargonidin-3-Oglucoside and cyanidin-3-O-glucoside were the most abundant anthocyanins. However, identification of metabolites of polyphenolic compounds is challenging due to their complexity and limited database information. Metabolized polyphenolic compounds could be transformed into structures not detected by currently available analytical methods. Discrepancy in available literature also makes it difficult to establish methods for analyzing anthocyanin derived metabolites, but these data were confirmed using Q-TOF LC/MS. This technology enables automatic acquisition of MS spectra and MS/MS in a single chromatographic injection. The Q-TOF analysis allows to obtain the exact mass of ions, which is essential for the assignment of elemental composition and therefore for characterization of small molecules. While Q-TOF LC/MS does not provide the ultimate detection limits compared to advanced triple-quadruple systems, its sensitivity is sufficient for compound assessment in bioavailability studies. It enables identification, profiling and structure elucidation of metabolites by producing high quality MS and MS/MS spectra with accurate isotope ratios. Combined with sophisticated data analysis software and databases, Q-TOF mass spectrometry provides a clear advantage over other technologies in non-targeted analysis of bioactives. The data extracted from Q-TOF LC/MS analysis allowed for detection of 7 previously undescribed compounds in plasma and also allowed for metabolite profiling based on time of first appearance. These data provide insight into the array of compounds that are generated, a sense of the time course of appearance of various compounds and a snapshot of variability among subjects (several were detected for the first time at the same time point and only 3 compounds were detected in less than the total sample set). Review articles tabulating the major compounds and metabolites detected after fruit consumption with their general kinetic profile (C max , T max ) have been published; [34, 35] however, an extensive qualitative profiling as shown in the present study has not been documented.
The Q-TOF technology, utilized also by Hanhineva in two studies on strawberry leaves and flowers [36, 37] , enables characterization of compounds based not only on accurate mass but also on fragmentation pattern of the parent ion, increasing the confidence in compound identification. Therefore, it was important to utilize the accuracy of nontargeted Q-TOF analysis in determining additional polyphenolic metabolites ( Table 7) and times of their appearance in plasma (Table 8) relevant to possible physiological effects on inflammation, oxidative stress and insulin resistance. Enriching the knowledge of postprandial plasma metabolites and their appearance over time can provide insight into further understanding of the impact of colonic microbiota on absorption and metabolism of dietary polyphenols and allow better perception of biological effect of the polyphenolic metabolites. The accuracy of mass data generated by Q-TOF LC/MS together with the fragmentation pattern of the full scan run of MS/MS analysis have been a useful tool to tentatively characterize phenolic compounds in the plasma matrix. Most of these compounds found in human plasma are being reported here for the first time. Full-spectrum acquisition at good sensitivity with Q-TOF analysis allowed detection and characterization of compounds, such as fisetin and its glycoside, not identified in the strawberry beverages analyzed by targeted LC-MS/MS. Nonetheless, both targeted and non-targeted approaches taken in this study are complementary and both have their advantages in determination of plasma metabolites.
